INFLAMMATION AND MOTILITY

Increased rectal mucosal expression of interleukin 1ß in recently acquired post-infectious irritable bowel syndrome

K-A Gwee¹, S M Collins², N W Read³, A Rajnakova¹, Y Deng², J C Graham⁴, M W McKendrick⁴, S M Moochhala⁵

¹ Department of Medicine, National University Hospital, Singapore
² Division of Gastroenterology, Intestinal Diseases Research Program, McMaster University, Hamilton, Ontario, Canada
³ Centre for Integrated Medicine, Coleridge House, Northern General Hospital, Sheffield S57AU, UK
⁴ Department of Infectious Diseases, Royal Hallamshire Hospital, Sheffield S10 2JF, UK
⁵ Combat Care and Performance Laboratories, Defence Medical Research Institute, DSTA, Singapore

Correspondence to:
Correspondence to:
Associate Professor K-A Gwee, Gleneagles Hospital, Annexe Block #05–37, 6A Napier Road, Singapore 258 500;
gwee_kok_ann{at}nus.edu.sg

Background and aims: Chronic bowel disturbances resembling irritable bowel syndrome (IBS) develop in approximately 25% of patients after an episode of infectious diarrhoea. Although we have previously shown that psychosocial factors operating at the time of, or prior to, the acute illness appear to predict the development of post-infectious IBS (PI-IBS), our finding of an increased inflammatory cell number in the rectum persisting for at least three months after the acute infection suggested that there is also an organic component involved in the development of PI-IBS. To evaluate this further, we measured expressions of interleukin 1ß (IL-1ß) and its receptor antagonist (IL-1ra) in these patients to provide additional evidence that the pathogenesis of PI-IBS is underpinned by an inflammatory process.

Methods: Sequential rectal biopsy samples were prospectively obtained during and three months after acute gastroenteritis, from eight patients who developed post-infectious IBS (INF-IBS) and seven patients who returned to normal bowel habits after acute gastroenteritis (infection controls, INF-CON). Eighteen healthy volunteers who had not suffered from gastroenteritis in the preceding two years served as normal controls (NOR-CON). IL-1ß and IL-1ra gene expressions were assayed by reverse transcriptase-polymerase chain reaction, and their levels of expression were quantitated by optical densitometry after electrophoresis on agarose gel.

Results: INF-IBS patients exhibited significantly greater expression of IL-1ß mRNA in rectal biopsies than INF-CON patients both during and three months after acute gastroenteritis. Moreover, IL-1ß mRNA expression had increased in biopsies taken from INF-IBS patients at three months after the acute infection but no consistent change was observed in INF-CON patients. IL-1ß mRNA expression of INF-IBS patients at three months post gastroenteritis was significantly greater than NOR-CON whereas that of INF-CON patients was not significantly different from NOR-CON. Despite these differential changes in IL-1ß mRNA expression, no significant changes were observed in IL-1ra mRNA expression among the three groups.

Conclusions: These findings indicate that those patients who develop IBS post infection exhibit greater IL-1ß mRNA expression, both during and after the infection, compared with individuals who do not develop PI-IBS. We conclude that such patients may be susceptible to inflammatory stimuli, and that inflammation may play a role in the pathogenesis of PI-IBS.

Keywords: interleukin 1ß; irritable bowel syndrome; post-infectious irritable bowel syndrome

Abbreviations: IBS, irritable bowel syndrome; PI-IBS, post-infectious IBS; IL-1ß, interleukin 1ß; IL-1ra, interleukin 1 receptor antagonist; PCR, polymerase chain reaction

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Barbara, G., Stanghellini, V. (2009). Biomarkers in IBS: when will they replace symptoms for diagnosis and management?. Gut 58: 1571-1575 [Full Text]  
• de Saussure, P. P. H. (2009). Review: Management of the returning traveler with diarrhea. Therapeutic Advances in Gastroenterology 2: 367-375 [Abstract]  
• Bercik, P., Verdu, E. F., Foster, J. A., Lu, J., Scharringa, A., Kean, I., Wang, L., Blennerhassett, P., Collins, S. M. (2009). Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R587-R594 [Abstract] [Full Text]  
• Vicario, M., Alonso, C., Santos, J. (2009). Impaired intestinal molecular tightness in the mucosa of irritable bowel syndrome: what are the mediators?. Gut 58: 161-162 [Full Text]  
• Wald, A., Rakel, D. (2008). Behavioral and Complementary Approaches for the Treatment of Irritable Bowel Syndrome. Nutr Clin Pract 23: 284-292 [Abstract] [Full Text]  
• Quigley, E. M M (2007). Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy?. J. Am. Coll. Nutr. 26: 684S-690S [Abstract] [Full Text]  
• Spiller, R, Aziz, Q, Creed, F, Emmanuel, A, Houghton, L, Hungin, P, Jones, R, Kumar, D, Rubin, G, Trudgill, N, Whorwell, P (2007). Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56: 1770-1798 [Abstract] [Full Text]  
• Roka, R., Ait-Belgnaoui, A., Salvador-Cartier, C., Garcia-Villar, R., Fioramonti, J., Eutamene, H., Bueno, L. (2007). Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats. Gut 56: 1072-1078 [Abstract] [Full Text]  
• Wang, B., Glatzle, J., Mueller, M. H., Kreis, M., Enck, P., Grundy, D. (2005). Lipopolysaccharide-induced changes in mesenteric afferent sensitivity of rat jejunum in vitro: role of prostaglandins. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G254-G260 [Abstract] [Full Text]  
• Lindley, K J, Glaser, D, Milla, P J (2005). Consumerism in healthcare can be detrimental to child health: lessons from children with functional abdominal pain. Arch. Dis. Child. 90: 335-337 [Abstract] [Full Text]  
• Spiller, R. C. (2005). Irritable bowel syndrome. Br Med Bull 72: 15-29 [Abstract] [Full Text]  
• Lin, H. C. (2004). Small Intestinal Bacterial Overgrowth: A Framework for Understanding Irritable Bowel Syndrome. JAMA 292: 852-858 [Abstract] [Full Text]  
• Collins, S M, Barbara, G (2004). East meets West: infection, nerves, and mast cells in the irritable bowel syndrome. Gut 53: 1068-1069 [Full Text]  
• Wang, L-H, Fang, X-C, Pan, G-Z (2004). Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 53: 1096-1101 [Abstract] [Full Text]  
• Spiller, R C (2004). Progress report. Gut 53: 317-317 [Full Text]